Insulinoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview= | ==Overview= | ||
Laboratory findings consistent with the diagnosis of insulinoma include | Laboratory findings consistent with the diagnosis of insulinoma include | ||
S. glucose <55 mg/dL<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155 }} </ref> | S. [[glucose]] <55 mg/dL<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155 }} </ref> | ||
S. Insulin >5-10 μU/mL | S. [[Insulin]] >5-10 μU/mL | ||
S. C-Peptide >200 pmol/L | S. [[C-peptide|C-Peptide]] >200 pmol/L | ||
S. proinsulin ≥ 22 pmol/L | S. [[proinsulin]] ≥ 22 pmol/L | ||
Patients with insulinoma may have elevated insulin to glucose ratio >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a gold standard test.<ref name="pmid18672144">{{cite journal| author=Callender GG, Rich TA, Perrier ND| title=Multiple endocrine neoplasia syndromes. | journal=Surg Clin North Am | year= 2008 | volume= 88 | issue= 4 | pages= 863-95, viii | pmid=18672144 | doi=10.1016/j.suc.2008.05.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18672144 }} </ref> | Patients with insulinoma may have elevated insulin to glucose ratio >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a [[Gold standard (test)|gold standard]] test.<ref name="pmid18672144">{{cite journal| author=Callender GG, Rich TA, Perrier ND| title=Multiple endocrine neoplasia syndromes. | journal=Surg Clin North Am | year= 2008 | volume= 88 | issue= 4 | pages= 863-95, viii | pmid=18672144 | doi=10.1016/j.suc.2008.05.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18672144 }} </ref> | ||
1/3rd or 33% patients have clinical symptoms with in 12 hours of the fasting. | 1/3rd or 33% patients have clinical symptoms with in 12 hours of the fasting. | ||
80% develop within 24 hours | 80% develop within 24 hours | ||
| Line 18: | Line 18: | ||
*Laboratory findings consistent with the diagnosis of insulinoma include | *Laboratory findings consistent with the diagnosis of insulinoma include | ||
** S. glucose <55 mg/dL<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155 }} </ref> | ** S. [[glucose]] <55 mg/dL<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155 }} </ref> | ||
** S. Insulin >5-10 μU/mL | ** S. [[Insulin]] >5-10 μU/mL | ||
** S. C-Peptide >200 pmol/L | ** S. [[C-Peptide]] >200 pmol/L | ||
** S. proinsulin ≥ 22 pmol/L | ** S. [[proinsulin]] ≥ 22 pmol/L | ||
*Patients with insulinoma may have elevated insulin to glucose ratio >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a gold standard test.<ref name="pmid18672144">{{cite journal| author=Callender GG, Rich TA, Perrier ND| title=Multiple endocrine neoplasia syndromes. | journal=Surg Clin North Am | year= 2008 | volume= 88 | issue= 4 | pages= 863-95, viii | pmid=18672144 | doi=10.1016/j.suc.2008.05.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18672144 }} </ref> | *Patients with insulinoma may have elevated [[insulin to glucose ratio]] >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a gold standard test.<ref name="pmid18672144">{{cite journal| author=Callender GG, Rich TA, Perrier ND| title=Multiple endocrine neoplasia syndromes. | journal=Surg Clin North Am | year= 2008 | volume= 88 | issue= 4 | pages= 863-95, viii | pmid=18672144 | doi=10.1016/j.suc.2008.05.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18672144 }} </ref> | ||
**1/3rd or 33% patients have clinical symptoms with in 12 hours of the fasting. | **1/3rd or 33% patients have clinical [[symptoms]] with in 12 hours of the fasting. | ||
**80% develop within 24 hours | **80% develop within 24 hours | ||
**90% develop within 48 hours | **90% develop within 48 hours | ||
Revision as of 10:13, 29 August 2017
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Insulinoma laboratory tests |
|
Risk calculators and risk factors for Insulinoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
=Overview
Laboratory findings consistent with the diagnosis of insulinoma include S. glucose <55 mg/dL[1] S. Insulin >5-10 μU/mL S. C-Peptide >200 pmol/L S. proinsulin ≥ 22 pmol/L Patients with insulinoma may have elevated insulin to glucose ratio >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a gold standard test.[2] 1/3rd or 33% patients have clinical symptoms with in 12 hours of the fasting. 80% develop within 24 hours 90% develop within 48 hours 100% develop within 72 hours
Laboratory Findings
- Laboratory findings consistent with the diagnosis of insulinoma include
- S. glucose <55 mg/dL[1]
- S. Insulin >5-10 μU/mL
- S. C-Peptide >200 pmol/L
- S. proinsulin ≥ 22 pmol/L
- Patients with insulinoma may have elevated insulin to glucose ratio >0.4, which is usually suggestive of insulinoma after a 72-hour fast test.It is a gold standard test.[2]
- 1/3rd or 33% patients have clinical symptoms with in 12 hours of the fasting.
- 80% develop within 24 hours
- 90% develop within 48 hours
- 100% develop within 72 hours
References
- ↑ 1.0 1.1 Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER; et al. (2009). "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 94 (3): 709–28. doi:10.1210/jc.2008-1410. PMID 19088155.
- ↑ 2.0 2.1 Callender GG, Rich TA, Perrier ND (2008). "Multiple endocrine neoplasia syndromes". Surg Clin North Am. 88 (4): 863–95, viii. doi:10.1016/j.suc.2008.05.001. PMID 18672144.